Supply Chain Management main glossary
This is a glossary of key terms used throughout the site.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
The sources used to obtain the data needed for M&E activities. These sources may include, among many others, official government documents, data from the logistics management information system, data from the health management information system, clinic administrative records, staff or provider information, client-visit registers, interview data, sentinel-surveillance systems, and satellite imagery.
Regulated administration of individual doses of medicines.
The quantity of a medication that is administered at a certain time.
Ecumenical Pharmaceutical Network
A process that attempts to determine as systematically and objectively as possible the relevance, effectiveness, and impact of activities in light of their objectives.
Excipients are the inactive ingredients in the finished pharmaceutical product (FPP) that do not have any pharmacological or therapeutic activity. Examples of excipients include fillers, coating agents, dyes, preservations, flavouring and colouring agents and so on. Lactose is a commonly used filler (also known as bulking agent) in tablets to give mass and/or volume to the substance, thereby facilitating the production process.
Finished pharmaceutical product
Finished Pharmaceutical Product (FPP) is the final product after all stages of manufacture including packaging in its final container and its labelling.
Finished product specifications
Finished product specifications is the set of tests and limits applicable to a finished pharmaceutical product (FPP), to ensure that every batch is of consistent quality at the time of release and throughout the shelf-life.
Formulation, in medicines, refers to the process in which different chemicals, including the active ingredient, are combined to produce a final medicinal product.